Lockett, J., Nicholson, G., Richards, N., Washington, R., & Nagre, N. (2026). HU308, A Selective Cannabinoid Type-2 Receptor Agonist, Mitigates SARS-COV-2 Spike Protein-Induced Acute Lung Injury in Mice. Department of Biomedical and Translational Sciences Faculty Publications. https://doi.org/10.1007/s00408-026-00870-6
Παραπομπή σε μορφή Chicago (17η εκδ.)Lockett, Janette, Gregory Nicholson, Nicholas Richards, Ryan Washington, και Nagaraja Nagre. "HU308, A Selective Cannabinoid Type-2 Receptor Agonist, Mitigates SARS-COV-2 Spike Protein-Induced Acute Lung Injury in Mice." Department of Biomedical and Translational Sciences Faculty Publications 2026. https://doi.org/10.1007/s00408-026-00870-6.
Παραπομπή σε μορφή MLA (9th εκδ.)Lockett, Janette, et al. "HU308, A Selective Cannabinoid Type-2 Receptor Agonist, Mitigates SARS-COV-2 Spike Protein-Induced Acute Lung Injury in Mice." Department of Biomedical and Translational Sciences Faculty Publications, 2026, https://doi.org/10.1007/s00408-026-00870-6.